AbbVie
ABBV
#25
Rank
โ‚น35.955 T
Marketcap
โ‚น20,344
Share price
1.80%
Change (1 day)
37.95%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2025 (TTM): โ‚น143.94 Billion

According to AbbVie's latest financial reports the company's current earnings are โ‚น59.64 Billion. In 2024 the company made an earning of โ‚น333.29 Billion a decrease over its 2023 earnings that were of โ‚น560.56 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AbbVie from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚น143.94 B-56.81%
2024 โ‚น333.29 B-40.54%
2023 โ‚น560.56 B-53.62%
2022 โ‚น1.208 T3.76%
2021 โ‚น1.164 T282.25%
2020 โ‚น304.77 B-59.67%
2019 โ‚น755.73 B62.13%
2018 โ‚น466.12 B-32.74%
2017 โ‚น693.04 B-1.99%
2016 โ‚น707.12 B18.65%
2015 โ‚น595.99 B180.5%
2014 โ‚น212.47 B-55.57%
2013 โ‚น478.23 B-6.86%
2012 โ‚น513.47 B56.05%
2011 โ‚น329.03 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น1.063 T 613.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น720.48 B 383.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2.018 T 1,255.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น739.41 B 396.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น886.68 B 495.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น170.77 B 14.70%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น836.18 B 461.62%๐Ÿ‡ฌ๐Ÿ‡ง UK
AstraZeneca
AZN
โ‚น1.174 T 688.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
โ‚น52.30 B-64.87%๐Ÿ‡บ๐Ÿ‡ธ USA